Literature DB >> 7094887

Hormone dependency in N-nitrosomethylurea-induced rat mammary tumors.

B M Arafah, H M Finegan, J Roe, A Manni, O H Pearson.   

Abstract

The majority (87%) of N-nitrosomethylurea-induced rat mammary tumors regressed within 1 week after hypophysectomy (hypox). After a hypox-induced tumor regression, ovine PRL (oPRL), and 17 beta-estradiol (E2) were administered separately or in combination in order to define the individual role of these hormones in regulating tumor growth and influencing estrogen (E), progesterone (Pg), and PRL receptor (R) levels. Administration of E2 (2.5 micrograms twice daily) or oPRL (20 IU daily, started 5 days after hypox and continued for 10 days, resulted in stabilization of tumor growth. Simultaneous administration of E2 and oPRL resulted in a synergistic effect and reactivation of tumor growth. ER levels in mammary tumors were significantly lower than those in the control 15 days after hypox (P less than 0.01). Treatment with E2, oPRL, or both simultaneously had no significant effect on ER levels. A significant decline in PgR levels was noted at both 5 and 15 days after hypox. Whereas treatment with oPRL had no significant effect on PgR levels, E2 administration either alone or in combination with oPRL restored PgR levels to control values. PRLR levels were unchanged from control values at 5 days, but significantly declined (P less than 0.005) 15 days after hypox. Treatment with E2, oPRL, or both hormones simultaneously partially maintained PRLR and prevented the decline to the extremely low level noted in the untreated group. We conclude that the growth of nitrosomethylurea-induced rat mammary tumors is dependent on both E2 and PRL. There was a synergistic effect between E2 and PRL on tumor growth but not on ER, PgR, or PRLR. Neither E2 nor PRL had any significant effect on ER after hypox. PgR is under E2 control. Either E2 or PRL or both hormones were able to maintain PRLR in mammary tumors after hypox.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7094887     DOI: 10.1210/endo-111-2-584

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  17 in total

1.  Selectivity of polyamine involvement in hormone action on normal and neoplastic target tissues of the rat.

Authors:  A Manni; B Badger; J Lynch; L Demers
Journal:  Breast Cancer Res Treat       Date:  1991 Jan-Feb       Impact factor: 4.872

2.  Kinetic and morphometric responses of heterogeneous populations of NMU-induced rat mammary tumor cells to hormone and antipolyamine therapy in vivo.

Authors:  A Manni; S Lancaster; H English; B Badger; J Lynch; L Demers
Journal:  Breast Cancer Res Treat       Date:  1991 Jan-Feb       Impact factor: 4.872

3.  Prognostic impact of progesterone receptor status combined with body mass index in breast cancer patients treated with adjuvant aromatase inhibitor.

Authors:  Masahiro Ohara; Etsushi Akimoto; Midori Noma; Kazuo Matsuura; Mihoko Doi; Naoki Kagawa; Toshiyuki Itamoto
Journal:  Oncol Lett       Date:  2015-08-28       Impact factor: 2.967

4.  Androgen-linked alkylating agents: biological activity in methylnitrosourea-induced rat mammary carcinoma.

Authors:  H P Brix; M R Berger; M R Schneider; W C Tang; G Eisenbrand
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

5.  Hormonal control of polyamine pools in experimental breast cancer in vivo: correlation with estrogen and progesterone receptor levels.

Authors:  A Manni; B Badger; J Lynch; P Glikman; L Demers
Journal:  Breast Cancer Res Treat       Date:  1989-11       Impact factor: 4.872

6.  Role of polyamines in the growth of hormone-responsive experimental breast cancer in vivo.

Authors:  A Manni; B Badger; G Luk; C Wright; R Caplan; H Rockette; M Bartholomew; S R Ahmed
Journal:  Breast Cancer Res Treat       Date:  1988-07       Impact factor: 4.872

7.  Investigations of droloxifene and other hormone manipulations on N-nitrosomethylurea-induced rat mammary tumours. 1. Influence on tumour growth.

Authors:  G Winterfeld; P Hauff; M Görlich; W Arnold; I Fichtner; H J Staab
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

8.  Role of transforming growth factor-alpha-related peptides in the autocrine/paracrine control of experimental breast cancer growth in vitro by estradiol, prolactin, and progesterone.

Authors:  A Manni; C Wright; B Badger; M Bartholomew; M Herlyn; J Mendelsohn; H Masui; L Demers
Journal:  Breast Cancer Res Treat       Date:  1990-02       Impact factor: 4.872

9.  Polyamines and estrogen control of growth of the NMU-induced rat mammary tumor.

Authors:  A Manni; C Wright; M Pontari
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

10.  Estrone sulfate: a potential source of estradiol in human breast cancer tissues.

Authors:  S J Santner; D Leszczynski; C Wright; A Manni; P D Feil; R J Santen
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.